Zhangzhou Pientzehuang Pharmaceutical | 600436 - Marktkapitalisierung

Aktienkurs
138.01
Täglich Wechseln
0.16 0.12%
Monatlich
-7.36%
Jährlich
-33.96%
Q2 Prognose
138.34




Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Avita Medical AUD 105.47M 35.32M 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Dianthus Therapeutics USD 1.78B 215M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
IQVIA Holdings USD 31.35B 2.72B 2026-05
Jiangsu Hengrui CNY 366.9B 29.67B 2026-03
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Moderna USD 20.15B 8.53B 2026-03
Revvity USD 11.4B 1.46B 2026-05
Tectonic Therapeutic USD 390M 96M 2025-12
Viatris USD 20.65B 4.92B 2026-05
Wuxi Apptec CNY 295.54B 26.09B 2026-03
Xeris Pharmaceuticals USD 1.3B 12M 2025-12